A Study to Evaluate Betrnet Stem Cells and the Origins of Barrett's Esophagus
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
NCT ID: NCT01568723
Sponsor Protocol Number: 11-006510
About this study
The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Barrett's esophagus with high grade dysplasia or intramucosal (early) adenocarcinoma.
- BE length ≥ 2 cm and ≤ 8 cm.
- Able to return every 3 months for one year after ablation.
Exclusion Criteria:
- Patients who are unable to be compliant with follow-up endoscopies.
- Patients who cannot tolerate proton pump inhibitors.
- Pre-existing esophageal strictures.
- Pregnant or nursing women.
More information
Publications
Publications are currently not available